Delivering the precision oncology paradigm: reduced R&D costs and greater return on investment through a companion diagnostic informed precision oncology medicines approach.
Saved in:
| Title: | Delivering the precision oncology paradigm: reduced R&D costs and greater return on investment through a companion diagnostic informed precision oncology medicines approach. |
|---|---|
| Authors: | Henderson, Raymond H.1,2,3,4 (AUTHOR) raymondhenderson@saluteminsights.com, French, Declan2 (AUTHOR), Stewart, Elaine2 (AUTHOR), Smart, Dave3 (AUTHOR), Idica, Adam5 (AUTHOR), Redmond, Sandra4 (AUTHOR), Eckstein, Markus6 (AUTHOR), Clark, Jordan3 (AUTHOR), Sullivan, Richard7 (AUTHOR), Keeling, Peter3 (AUTHOR), Lawler, Mark1 (AUTHOR) |
| Source: | Journal of Pharmaceutical Policy & Practice. 7/5/2023, Vol. 16 Issue 1, p1-10. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20523211 |
|---|---|
| DOI: | 10.1186/s40545-023-00590-9 |
